2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$9.55-$0.09 (-0.93%)
Price as of Jul 14, 2026 4:10 AM EDT- $695.3MMarket Cap
- 49.92%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$9.55-$0.09 (-0.93%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.64 | ||
Change | +$0.15 (+1.58%) | ||
Open | $9.70 | ||
High | $9.88 | ||
Low | $9.19 | ||
Previous Close | $9.49 | ||
Volume | 1,627,554 | ||
30-Day Average Volume | 2,144,233 | ||
1-Week Change | -3.89% | ||
1-Month Change | 12.62% | ||
1-Year Change | 49.92% | ||
3-Year Change | 703.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $201.9M | ||
Market Cap | $695.3M | ||
Enterprise Value | $548.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$7.3M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $190.7M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -68 | ||
PEG | -1 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue